IL-6/ERK signaling pathway participates in type I IFN-programmed, unconventional M2-like macrophage polarization

Type I interferons (IFN-Is) have been harnessed for cancer therapies due to their immunostimulatory functions. However, certain tumor-tolerating activities by IFN-Is also exist, and may potentially thwart their therapeutic effects. In this respect, our previous studies have demonstrated a monocyte-o...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Limin, Guo, Panpan, Wang, Pei, Wang, Wei, Liu, Jianghuai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892596/
https://www.ncbi.nlm.nih.gov/pubmed/36726024
http://dx.doi.org/10.1038/s41598-022-23721-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892596/
https://www.ncbi.nlm.nih.gov/pubmed/36726024
http://dx.doi.org/10.1038/s41598-022-23721-9

Ejemplares similares